CoreCap Advisors’s Biohaven BHVN Stock Holding History

CoreCap Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$227	Hold	17	–	–	﹤0.01%	2937
2026 Q2	$253	Hold	17	–	–	﹤0.01%	2978
2026 Q1	$144	Hold	17	–	–	﹤0.01%	2798
2025 Q4	$192	Buy	+17	New	+$211	﹤0.01%	2818
2025 Q2	–	Sell	-60	Closed	-$1.44K	–	2816
2025 Q1	$1.44K	Buy	60 +29	+94%	+$1.02K	﹤0.01%	2443
2024 Q4	$1.16K	Buy	+31	New	+$1.45K	﹤0.01%	2353

Other funds holding BHVN

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

GWM

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

CoreCap Advisors's BHVN Position: Q3 2026 in Review

CoreCap Advisors held its Biohaven (BHVN) position steady in Q3 2026 at 17 shares worth $227. The position accounts for ﹤0.01% of the portfolio, ranked #2937.

CoreCap Advisors first reported a position in BHVN in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.44K in Q1 2025. 6 funds tracked by Wall St. Rank hold BHVN as of Q3 2026.

CoreCap Advisors held 17 shares of Biohaven worth $227 as of Q3 2026.
CoreCap Advisors left its Biohaven share count unchanged in Q3 2026.
Biohaven made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2937 holding.
CoreCap Advisors first reported a position in Biohaven in Q4 2024 and has held it in 6 quarters since.
CoreCap Advisors's Biohaven position peaked at $1.44K in Q1 2025.
6 funds tracked by Wall St. Rank held Biohaven as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.